James Ballenger to Benzodiazepinones
This is a "connection" page, showing publications James Ballenger has written about Benzodiazepinones.
Connection Strength
0.030
-
A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder. Biol Psychiatry. 1995 Apr 01; 37(7):462-6.
Score: 0.030
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.